These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 28185918)

  • 1. Warfarin use and the risk of mortality, stroke, and bleeding in hemodialysis patients with atrial fibrillation.
    Kai B; Bogorad Y; Nguyen LN; Yang SJ; Chen W; Spencer HT; Shen AY; Lee MS
    Heart Rhythm; 2017 May; 14(5):645-651. PubMed ID: 28185918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between warfarin use and incidence of ischemic stroke in Japanese hemodialysis patients with chronic sustained atrial fibrillation: a prospective cohort study.
    Wakasugi M; Kazama JJ; Tokumoto A; Suzuki K; Kageyama S; Ohya K; Miura Y; Kawachi M; Takata T; Nagai M; Ohya M; Kutsuwada K; Okajima H; Ei I; Takahashi S; Narita I
    Clin Exp Nephrol; 2014 Aug; 18(4):662-9. PubMed ID: 24113782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation.
    Shen JI; Montez-Rath ME; Lenihan CR; Turakhia MP; Chang TI; Winkelmayer WC
    Am J Kidney Dis; 2015 Oct; 66(4):677-88. PubMed ID: 26162653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin Use in Patients With Atrial Fibrillation Undergoing Hemodialysis: A Nationwide Population-Based Study.
    Yoon CY; Noh J; Jhee JH; Chang TI; Kang EW; Kee YK; Kim H; Park S; Yun HR; Jung SY; Oh HJ; Park JT; Han SH; Kang SW; Kim C; Yoo TH
    Stroke; 2017 Sep; 48(9):2472-2479. PubMed ID: 28801476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis.
    Van Der Meersch H; De Bacquer D; De Vriese AS
    Am Heart J; 2017 Feb; 184():37-46. PubMed ID: 27892885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
    Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
    Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke, Major Bleeding, and Mortality Outcomes in Warfarin Users With Atrial Fibrillation and Chronic Kidney Disease: A Meta-Analysis of Observational Studies.
    Dahal K; Kunwar S; Rijal J; Schulman P; Lee J
    Chest; 2016 Apr; 149(4):951-9. PubMed ID: 26378611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation.
    Winkelmayer WC; Liu J; Setoguchi S; Choudhry NK
    Clin J Am Soc Nephrol; 2011 Nov; 6(11):2662-8. PubMed ID: 21959598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis.
    Tan J; Liu S; Segal JB; Alexander GC; McAdams-DeMarco M
    BMC Nephrol; 2016 Oct; 17(1):157. PubMed ID: 27769175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Warfarin on Ischemic Stroke, Bleeding, and Mortality in Patients with Atrial Fibrillation Receiving Peritoneal Dialysis.
    Phan D; Yang SJ; Shen AY; Lee MS
    Am J Cardiovasc Drugs; 2019 Oct; 19(5):509-515. PubMed ID: 31016691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin use and incidence of stroke in Japanese hemodialysis patients with atrial fibrillation.
    Yodogawa K; Mii A; Fukui M; Iwasaki YK; Hayashi M; Kaneko T; Miyauchi Y; Tsuruoka S; Shimizu W
    Heart Vessels; 2016 Oct; 31(10):1676-80. PubMed ID: 26646256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis.
    Harel Z; Chertow GM; Shah PS; Harel S; Dorian P; Yan AT; Saposnik G; Sood MM; Molnar AO; Perl J; Wald RM; Silver S; Wald R
    Can J Cardiol; 2017 Jun; 33(6):737-746. PubMed ID: 28545622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
    Banerjee A; Clementy N; Haguenoer K; Fauchier L; Lip GY
    Am J Med; 2014 Oct; 127(10):972-8. PubMed ID: 24929021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation.
    Keskar V; McArthur E; Wald R; Harel Z; Zimmerman D; Molnar AO; Garg AX; Lam NN; McCallum MK; Bota SE; Perl J; Sood MM
    Kidney Int; 2017 Apr; 91(4):928-936. PubMed ID: 28017326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.
    Villines TC; Schnee J; Fraeman K; Siu K; Reynolds MW; Collins J; Schwartzman E
    Thromb Haemost; 2015 Nov; 114(6):1290-8. PubMed ID: 26446456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin use and the risk of stroke, bleeding, and mortality in older adults on dialysis with incident atrial fibrillation.
    Tan J; Bae S; Segal JB; Zhu J; Alexander GC; Segev DL; McAdams-DeMarco M
    Nephrology (Carlton); 2019 Feb; 24(2):234-244. PubMed ID: 29219209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of hemodialysis patients with atrial fibrillation: The RAKUEN (Registry of atrial fibrillation in chronic kidney disease under hemodialysis from Niigata) study.
    Mitsuma W; Matsubara T; Hatada K; Imai S; Saito N; Shimada H; Miyazaki S
    J Cardiol; 2016 Aug; 68(2):148-55. PubMed ID: 26527113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' Characteristics Affect the Survival Benefit of Warfarin Treatment for Hemodialysis Patients with Atrial Fibrillation. A Historical Cohort Study.
    Brancaccio D; Neri L; Bellocchio F; Barbieri C; Amato C; Mari F; Canaud B; Stuard S
    Am J Nephrol; 2016; 44(4):258-267. PubMed ID: 27598317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intersection of risk and benefit: is warfarin anticoagulation suitable for atrial fibrillation in patients on hemodialysis?
    Sood MM; Komenda P; Sood AR; Rigatto C; Bueti J
    Chest; 2009 Oct; 136(4):1128-1133. PubMed ID: 19809054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.